# Comparison of Sutureless Vs. Standard Biological Prostheses for Surgical Aortic Valve Replacement

Study · id `cardio:ct-nct03965065` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03965065](<https://clinicaltrials.gov/study/NCT03965065>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03965065

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 350 participants.

## Technical summary

Registry record NCT03965065. Randomized; double masking; primary purpose treatment. Start 2019-06-02 (actual); primary completion 2020-05-30 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 350 participants (planned count; ClinicalTrials.gov record NCT03965065, source copy `cardio:ctgov-nct03965065-2020-02-20`, retrieved 2026-10-26)
- Started: 2019-06-02 (actual) (ClinicalTrials.gov record NCT03965065, source copy `cardio:ctgov-nct03965065-2020-02-20`, retrieved 2026-10-26)
- Primary completion: 2020-05-30 (anticipated) (ClinicalTrials.gov record NCT03965065, source copy `cardio:ctgov-nct03965065-2020-02-20`, retrieved 2026-10-26)
- Completion: 2020-05-30 (anticipated) (ClinicalTrials.gov record NCT03965065, source copy `cardio:ctgov-nct03965065-2020-02-20`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT03965065, source copy `cardio:ctgov-nct03965065-2020-02-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03965065-2020-02-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: Comparison of Sutureless Vs. Standard Biological Prostheses for Surgical Aortic Valve Replacement
- Acronym: COPERA
- Condition: Heart Valve Prosthesis
- Condition: Aortic Stenosis
- Condition: Hemodynamics
- Intervention (Device): Sutureless aortic bioprosthesis
- Intervention (Device): Conventional stented sutured aortic prosthesis
- Lead sponsor: Hospital San Carlos, Madrid
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Hospital San Carlos, Madrid (`cardio:org-hospital-san-carlos-madrid`)

## Provenance

Content hash: b9e81b33443c4f79b85f49424bce81e4eef5bf3de62034cd02adad7e6c5a288c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
